Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefdinir Oral Suspension in Pediatric Acute Otitis Media
NCT00645203Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2002
- Primary completion
- Apr 2003
- Modality
- Reversible Covalent Inhibitors
- Countries
- 7
01
Overview
A Phase 3 trial of cefdinir in acute otitis media (AOM), sponsored by Abbott Laboratories. Started Jul 2002; status: completed.
02
Drugs
cefdinir
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00645203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645203.